Digitalization

Photo

Trusted Evidence in the Age of AI

AI in pharma has moved past the hype cycle and into implementation. The organizations that pull ahead won't have the most sophisticated models — they'll have the strongest evidence foundation underneath them.

Photo

Product and Service in Balance

Innovative supply‑chain solutions turn logistics into a competitive edge by boosting reliability, transparency, resilience, and sustainability, helping chemical companies win customers and differentiate in the market

Photo

Navigating the Future of Chemical Distribution

In 2024, the chemical distribution industry is at a pivotal moment, navigating both challenges and new opportunities. As distributors grapple with a landscape shaped by shifting global trade routes, demand constraints, and digital disruption, their roles are evolving far beyond traditional bulk breaking.

Photo

“Quo vadis, Europe?”

Today, economic success is defined by a different perception and practice of supply capability and supply security. This applies not only to the European trade with chemicals but to the entire chemical value chain.

Photo

Pharma’s Digital Transformation

Industry experts Michelangelo Canzoneri, Josef Trapl, Wolfgang Winter, Christian Woelbeling, and Thomas Zimmer – all members of ISPE’s Pharma 4.0 guide core team – explain the transformational challenges and critical success factors of the digital Pharma 4.0 journey.

Photo

Chemical Labor Productivity Challenge

The chemical industry faces acute labor shortages because the talent pool is shrinking, but the industry remains heavily reliant on manual work. Therefore, realizing labor productivity potential will be decisive for business continuity and future growth.

Photo

Navigating the Logistics Impact

Cell and gene therapies (CGTs) present a revolutionary approach to the pharmaceutical industry. However, several complexities do arise on a logistical spectrum that diverge from those of traditional pharmaceuticals.

91 more articles

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.